» Articles » PMID: 10795516

Improvement of a Serodiagnostic Strategy for Foot-and-mouth Disease Virus Surveillance in Cattle Under Systematic Vaccination: a Combined System of an Indirect ELISA-3ABC with an Enzyme-linked Immunoelectrotransfer Blot Assay

Overview
Journal Arch Virol
Specialty Microbiology
Date 2000 May 5
PMID 10795516
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Foot-and-mouth disease (FMD) recombinant non-capsideal viral antigens 3A, 3B, 2C, 3D and 3ABC were assessed individually in an indirect enzyme-linked immunosorbent assay (I-ELISA) for their ability to screen for persistent infection-specific antibodies in cattle, regardless of vaccination condition. Results of sequential serum samples from non-vaccinated animals with experimentally induced persistent infection, and their correlation with virus isolation, indicated that the polypeptides 3A, 3B and 3ABC showed the most adequate characteristics for further field studies. Reliable performance of the I-ELISA with the selected antigen 3ABC was indicated by the distinct patterns observed for the frequency distribution values of naive and true positive samples. For regularly vaccinated livestock, a clear negative profile was proved in samples from regions without recent history of FMD. In contrast, at 90 and 900 days post-outbreak, coexistence of a positive and a negative population was established. These findings indicated that, irrespective of vaccination, the test allowed a classification of the herd-disease status. A high degree of agreement was observed between I-ELISA-3ABC and EITB results for clearly reactive and non-reactive sera. For samples with reactivity values close to that of the cut-off, the EITB profiles upheld the definition of the infection condition. On this basis, screening by I-ELISA-3ABC, together with confirmation of suspect or positive samples by EITB is proposed as an adequate and accurate approach for large-scale epidemiological surveillance.

Citing Articles

Seroprevalence and molecular detection of foot and mouth disease virus in cattle in selected districts of Wolaita Zone, Southern Ethiopia.

Bandaw T, Gebremeskel H, Muluneh A, Mengistu T, Kebede I Sci Rep. 2024; 14(1):7929.

PMID: 38575673 PMC: 10994912. DOI: 10.1038/s41598-024-57404-4.


The Immunogenicity of a Foot-and-Mouth Disease Virus Serotype O Vaccine in Commercial and Subsistence Cattle Herds in Zambia.

Banda F, Ludi A, Wilsden G, Browning C, Kangwa H, Mooya L Vaccines (Basel). 2023; 11(12).

PMID: 38140222 PMC: 10747988. DOI: 10.3390/vaccines11121818.


A gold nanoparticle strip for simultaneously evaluating FMDV immunized antibody level and discriminating FMDV vaccinated animals from infected animals.

Yang S, Sun Y, Yang J, Liu Y, Feng H, Zhang G RSC Adv. 2022; 9(52):30164-30170.

PMID: 35530212 PMC: 9072146. DOI: 10.1039/c9ra04810c.


Seroprevalence and Molecular Detection of Foot and Mouth Disease Virus in Dairy Cattle Around Addis Ababa, Central Ethiopia.

Awel S, Dilba G, Abraha B, Zewde D, Wakjira B, Aliy A Vet Med (Auckl). 2021; 12:187-197.

PMID: 34285888 PMC: 8285296. DOI: 10.2147/VMRR.S317103.


Novel Foot-and-Mouth Disease Vaccine Platform: Formulations for Safe and DIVA-Compatible FMD Vaccines With Improved Potency.

Hardham J, Krug P, Pacheco J, Thompson J, Dominowski P, Moulin V Front Vet Sci. 2020; 7:554305.

PMID: 33088833 PMC: 7544895. DOI: 10.3389/fvets.2020.554305.